Pharmaceutical manufacturers of Naloxone

Sanofi is a global healthcare leader committed to improving lives around the world. With a strong focus on research and development, Sanofi strives to transform scientific innovation into healthcare solutions that address unmet medical needs. The company's extensive portfolio spans prescription medicines, vaccines, consumer healthcare products, and biopharmaceuticals, covering a wide range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology, rare diseases, and vaccines.

Jiangsu Nhwa Pharmaceutical Co., Ltd. was initially founded in 1978. In year 2008, Nhwa listed on the Shenzhen stock exchange with the stock code 002262. NHWA Pharma integrates R&D, production and sales together, as national psychiatric drugs designated unit, national high-tech enterprise, China’s top 100 pharmaceutical enterprises, national intellectual property rights demonstration unit, national "20 years 20 star" medical quality management enterprise star unit, international environmental certification (ISO14000) confirmed enterprise, the first batch of innovative enterprises in Jiangsu province, and vice President unit of China narcotic drug association.

Sun Pharma is a global, comprehensive, specialized pharmaceutical company with production facilities for API and FDF in India, the United States, Latin America, and Europe. It produces and sells a wide range of pharmaceutical formulations as branded generics and generic drugs in India, the US, and various other global markets. It is supported by 2 advanced R&D Centers with a team of over 600 scientists for projects in Chemical Synthesis, Clinical Research, and formulation development. Sun is a frontrunner in specific therapy areas and possesses robust expertise in product development, process chemistry, and manufacturing.

Aspen CDMO offers customized manufacturing services for Finished Dosage Forms across two continents: Europe and Africa. The primary dosage forms include injectables such as pre-filled syringes, liquid and lyophilized vials, BFS ampoules, and infusion bags, as well as tablets, creams, ointments, sprays, and BFS ampoules for nebulizers. It operates three advanced facilities in France.

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.

Euroapi focuses on revolutionizing active component solutions to sustainably fulfill the demands of clients and patients globally. As a prominent figure in active pharmaceutical ingredients, we possess a comprehensive portfolio of around 200 products, encompassing a wide range of technologies, and are constantly developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO). Our 3,350 employees are driven by the commitment to improving access to essential therapies and promoting health

Siegfried serves as your favored associate for comprehensive integrated pharmaceutical ingredient and drug product services with manufacturing capabilities globally. Our expertise is crucial for your venture throughout the entire lifespan. Our enthusiasm lies in creating and producing formulations. It is extraordinary for a provider of development and manufacturing services to possess such a blend of inherent technical expertise and knowledge. Pharmaceutical ingredient services entail Tailored Development and Outsourced Manufacturing for both active pharmaceutical ingredients (API) and intermediates, along with our own range of API (opiates and other regulated substances) and documentation featuring independent patented technologies. Clients utilizing our drug product services benefit from a wealth of inherited expertise in intricate oral drug delivery systems, including sterile filling, backed by in-house development, customer development and manufacturing, and a wide array of completed dosage form products. Enhancing chemical processes and formulations is our area of specialization. We collaborate closely with clients to innovate and enhance chemical processes, thus providing additional benefits and value. Siegfried operates at 11 locations globally, spanning both the Eastern and Western Hemispheres, with multi-purpose cGMP chemical manufacturing facilities in Zofingen, Switzerland; Pennsville, New Jersey, USA; Nantong, China; Minden, Germany; Saint-Vulbas, France; Evionnaz, Switzerland; and sites for manufacturing drug products in Zofingen, Switzerland; Malta; Hameln, Germany, Irvine, USA; Barberà del Vallès, Spain and El Masnou, Spain. Count on Siegfried as your preferred partner for more opportunities.

Veranova boasts over 50 years of expertise and is a frontrunner in the creation and fabrication of intricate and specialized APIs for the pharmaceutical and biotech sectors. It was previously a segment of Johnson Matthey, specializing in intricate and regulated chemical processes. The company delivers customized services throughout all phases of drug development and is split into Generics and Originators. It possesses a variety of development technologies and areas of expertise, along with a cooperative approach to API manufacturing and procedures.

MNK’s Specialty Generics division provides a wide variety of high-quality generic medications, focusing on pain relief, addiction treatment, and ADHD, as well as a comprehensive range of active pharmaceutical ingredients (APIs), such as acetaminophen/paracetamol, DEA scheduled compounds, and stearates. We run the largest API facility in the United States. Discover the range of excipients available from Mallinckrodt Pharmaceuticals for use in pharmaceutical drug delivery systems (DDS).

Rusan Pharma is a fully integrated global pharmaceutical corporation specializing in addiction treatment and pain management. The company manufactures and markets a diverse range of API and finished formulations, particularly focusing on controlled (narcotic and psychotropic) substances. Rusan's facilities hold GMP approval from Health Canada, EU, TGA, ANVISA, PIC/S, WHO, Russia, and SAHPRA. Additionally, Rusan has CEP approval for various APIs including Buprenorphine, Fentanyl, Naltrexone, Methadone, Bisoprolol, and also produces Naloxone, Nalbuphine, Nalmefene, Apomorphine, Efflornithine, and Sodium Oxybate. The company also develops and manufactures a variety of transdermal patches and long-acting formulations such as depot injections and implants.

We are the largest pharmaceutical company in Slovakia with site originally established in the 1940s. Our multi-purpose headquarters is easily reachable from all central European hubs like Vienna, Prague and Budapest. We, at Saneca, are proud of our tradition and reputation. We help improve the quality of life.

Established in 1997, Temad Co. has been operating for over two decades and is recognized as one of the leading manufacturers of APIs in Iran. It is also known for its groundbreaking production of both narcotic and non-narcotic products with exceptional quality within the Middle East. In addition to adhering to Iranian GMP regulations, Temad has met the national and international standards of API manufacturing, including ISO 9001/14001/17025/45001 and OHSAS 18001. With a portfolio of over 115 pharmaceutical products, Temad ensures compliance with GMP and WHO standards as well as regulations for both narcotic and non-narcotic medications. The company proudly exports its diverse range of products to 45 countries across the globe.

Pluvia Consumer Health operates as a multinational pharmaceutical firm and is headquartered in Istanbul, Turkey. The company possesses unique molecules and expertise. Its product portfolio comprises distinct APIs and Finished Dosage Form medications focusing on opioid medications, cosmeceuticals, and nutraceutical supplements, all supported by modern processing systems. The company's ability to manufacture its products in-house, leveraging its proprietary know-how from A to Z, enables it to provide comprehensive support in documentation, formulation, and scientific matters, as well as supply high-quality products at unbeatable prices, covering various types of APIs.

SpecGx manufactures a portfolio of generic pharmaceutical products, including certain opioid products for pain management. SpecGX is a subsidiary of Mallinckrodt Pharmaceuticals based in Saint Louis, MO.

Founded in 1932 in Milan, it was the first company authorised to process opiates for the pharmaceutical industry. Even today it is the only manufacturing company (authorized to produce narcotic substances) existing in our country. Our goal is to produce active pharmaceutical ingredients respecting the highest quality standards aimed at pain therapy. At every stage of the production process we strive to optimize resources, maintain a high level of quality and follow the indications dictated by the regulations in force.

Zhijun, as a subsidiary of the top pharmaceutical group in China, SINOPHARM Group, is the leading producer of Cephalosporin antibiotics finished formulation and active pharmaceutical ingredients. In addition to holding top market share in China for several products, these items have also been shipped to the EU, Africa, and South Asia. Zhijun has obtained the EU GMP certificate for cephalosporin injectable and tablet, showcasing its commitment to quality and international standards.